Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Aspira Women's Health Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- −2 vs. Q1 2021
- Shares held
- 31.0M
- −338.7K (−1.1%) vs. Q1 2021
- Total value
- $174.1M
- −$37.4M (−17.7%) vs. Q1 2021
- New holders
- 20
- 21 more added
- Sold out
- 22
- 32 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MYDA Advisors LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −35,330−100.0% | Sold out |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −31,500−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −15,024−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −13,061−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −11,340−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −10,705−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −6,049−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −5,170−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −3,242−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −2,750−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −2,087−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −239−100.0% | Sold out |